Any stock, in context
NATCOPHARM · Healthcare
NATCO Pharma Ltd.
Observation · 15 Oct 2026
How these are readNATCO Pharma closed at ₹785.0 on 15 Oct 2026, 16.0% below its 200-day average and 7.5% below its 50-day average: below both lines. It sits 34.8% below its highest close of the past year, in the bottom fifth of its one-year range. Over three months it fell 16.8%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- New 52-week low this week
- vs 200-day
- −16.0%
- the long line
- vs 50-day
- −7.5%
- the short line
- From 52w high
- −34.8%
- ₹779.0₹1,226.8
- 3 months
- −16.8%
- sector median −2.7% · 127 of 146
Nifty Smallcap 250 · Healthcare · EQ series · median traded value ₹31 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- +0.29%
- 1W
- –
- 1M
- −4.17%
- 3M
- −16.80%
- YTD
- –
- 1Y
- −3.81%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.